Pregled bibliografske jedinice broj: 1062970
The role of de novo expressed sirtuin 3 in triple negative human breast cancer cells upon oxidative stress
The role of de novo expressed sirtuin 3 in triple negative human breast cancer cells upon oxidative stress // Society for Free Radical Research Europe (SFRRE) Annual Meeting Abstracts "Redox Homeostasis: From Signaling to Damage". Free Radical Biology and Medicine, Vol.139, Suppl. 1
Ferrara, Italija: Elsevier, 2019. 138, 1 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1062970 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The role of de novo expressed sirtuin 3 in
triple negative human breast cancer cells upon
oxidative stress
Autori
Pinterić, Marija ; Podgorski, Iva I. ; Sobočanec, Sandra ; Popović Hadžija, Marijana ; Filić, Vedrana ; Ciganek, Ivan ; Pleše, Denis ; Marčinko, Dora ; Balog, Tihomir
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Society for Free Radical Research Europe (SFRRE) Annual Meeting Abstracts "Redox Homeostasis: From Signaling to Damage". Free Radical Biology and Medicine, Vol.139, Suppl. 1
/ - : Elsevier, 2019
Skup
SFRRE 2019 Annual Meeting: Redox homeostasis: from signaling to damage
Mjesto i datum
Ferrara, Italija, 19.06.2019. - 21.06.2019
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
hyperoxia ; sirtuin 3 ; triple negative breast cancer ; MDA-MB-231 ; oxidative stress
Sažetak
Hyperoxic treatment (inducer of reactive oxygen species, ROS) was shown to support some tumorigenic properties, but finally suppresses growth of certain mammary carcinoma cells. While estrogen receptor α cancers are more receptive to hormonal therapy, triple negative breast cancers (TNBC) are characterized by an aggressive behaviour and the lack of targeted therapeutic strategies. Sirtuin 3 (Sirt3), a major mitochondrial NAD+-dependent deacetylase, has bifunctional role in cancer tumorigenesis depending on the tissue and cancer-type specific metabolic programs. Due to strikingly reduced Sirt3 level in many breast cancer cells, we hypothesized it would have tumor suppressive effect in TNBC cells. Therefore, we stably transfected MDA-MB-231 cells with Flag- tagged Sirt-3 or empty plasmid and exposed cell to hyperoxic treatment. We are checking the expression of the proteins involved in mitochondrial biogenesis, metabolic regulation and antioxidant defence. Furthermore, we are investigating growth rate, metabolic activity and mitochondrial function through cellular respiration and FACS analysis. The surprising finding that Sirt-3 markedly promoted metabolic activity of TNBC cells, but reduced their potential to form new colonies and induced the mitochondrial ROS production compared to control cells gave us a rationale for more detailed studies on Sirt3 and hyperoxia as an adjuvant tumor therapy in TNBC cells.
Izvorni jezik
Engleski
Znanstvena područja
Biologija
POVEZANOST RADA
Projekti:
HRZZ-IP-2014-09-4533 - Sirtuin3 kao posrednik mitohondrijske funkcije u estrogen-ovisnoj otpornosti na oksidativni stres i prehranu s visokim udjelom masti (SuMERA) (Balog, Tihomir, HRZZ - 2014-09) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Tihomir Balog
(autor)
Marijana Popović-Hadžija
(autor)
Iva Škrinjar
(autor)
Vedrana Filić Mileta
(autor)
Marija Pinterić
(autor)
Sandra Sobočanec
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE